"Short" thrombelastography as a test of platelet reactivity in response to antiplatelet therapy: Validation and reproducibility

Platelets

Volumn 22, Issue 3, 2011, Pages 210-216

  Sambu, Nalyaka ^a,b   Hobson, Alex ^a   Curzen, Nick ^a,b,c  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

antiplatelet therapy; clotting; Thrombelastography

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CLOPIDOGREL; PURINERGIC P2Y12 RECEPTOR; THROMBIN;

AMPLITUDE MODULATION; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG MEGADOSE; HUMAN; INTERMETHOD COMPARISON; LOADING DRUG DOSE; LOW DRUG DOSE; MULTIPLE CYCLE TREATMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; RETROSPECTIVE STUDY; THROMBOCYTE; THROMBOELASTOGRAPHY; TREATMENT RESPONSE; VALIDATION STUDY;

ASPIRIN; BLOOD PLATELETS; HUMANS; INDIVIDUALITY; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; REPRODUCIBILITY OF RESULTS; THROMBELASTOGRAPHY; TICLOPIDINE;

EID: 79954510550     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2010.543201     Document Type: Article

References (37)

1. Gori A, Marcucci R, Migliorini A, Valenti R, Moschi G, Paniccia R, et al. Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents. J Am Coll Cardiol 2008;52:734-739.
2. Bliden K, DiChiara J, Tantry U, Bassi A, Chaganti S, Gurbel P. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention. Is the current antiplatelet therapy adequate? J Am Coll Cardiol 2007;49:657-666. (Pubitemid 46205039)
3. Buonamici P, Marcucci R, Migliorini A, Gensini G, Santini A, Paniccia R, et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 2007;49:2312-2317. (Pubitemid 46891710)
4. Lev E, Patel R, Maresh K, Guthikonda S, Granada J, DeLao T, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention. The role of dual drug resistance. J Am Coll Cardiol 2006;47:27-33. (Pubitemid 43005160)
5. Hochholzer W, Trenk D, Bestehorn HP, Fischer B, Valina C, Ferenc M, et al. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement. J Am Coll Cardiol 2006;48:1742-1750. (Pubitemid 44648629)
6. Wenaweser P, Dö rffler-Melly J, Imboden K, Windecker S, Togni M, Meier B, et al. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 2005;45:1748-1752. (Pubitemid 40779850)
7. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol E. A prospective blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:961-965. (Pubitemid 36315537)
8. Hartert H. Thrombelastography, a method for physical analysis of blood coagulation. Z Gesampte Exp Med 1951; 117:189-203.
9. Luddington RJ. Thrombelastography/thrombelastometry. Clin Lab Haem 2005;27:81-90.
10. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thrombelastography-guided transfusion algorithm reduces transfusion complex cardiac surgery. Anesth Analg 1999;88:312-319. (Pubitemid 29070189)
11. Kelly GA, Tuddenham EG. Haemostatic problems in liver disease. Gut 1986;27:339-349.
12. Kang YG, Martin DJ, Marquez J, Bugbee AC, Iwatsuki S, Griffith BP, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985;64:888-896. (Pubitemid 15015038)
13. Tantry U, Bliden K, Gurbel P. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol 2005; 46:1705-1709. (Pubitemid 41531626)
14. Gurbel PA, Bliden KP, Gruger K, Cho PW, Zaman KA, Kreutz PR, et al. Platelet Reactivity in Patients and Recurrent Events Post-Stenting: Results of the PREPARE Post-Stenting Study. J Am Coll Cardiol 2005;46:1820-1826. (Pubitemid 41579802)
15. Craft RM, Chavez JJ, Bresee SY, Wortham DC, Cohen E, Caroll RC. A novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004;143:301-309. (Pubitemid 38586495)
16. McGrath DJ, Ceboni E, Frumento RJ, Hirsh AL, Bennett GE. Thrombelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005;100:1576-1583. (Pubitemid 40712703)
17. Hobson A, Petley G, Dawkins K, Curzen N. A novel 15 minute test for assessment of individual time-dependent clotting responses to aspirin and clopidogrel using modified Thrombelastography. Platelets 2007;18:497-505. (Pubitemid 350034856)
18. Swallow R, Agarwala R, Dawkins K, Curzen N. Thrombelastography: a novel bedside tool to assess the effects of antiplatelet therapy? Platelets 2006;17:385-392. (Pubitemid 44410502)
19. Hobson A, Agarwala R, Swallow R, Dawkins K, Curzen N. Thrombelastography: Current clinical applications and its potential role in interventional cardiology. Platelets 2006; 17:509-518. (Pubitemid 44837721)
20. Hobson A, Petley G, Morton G, Dawkins K, Curzen N. Pointof- care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with drugeluting stent thrombosis whilst on dual antiplatelet therapy. Thromb J 2008;21:1-6.
21. Hobson A, Dawkins K, Curzen N. Antiplatelet effects of licking an aspirin tablet can be detected by thrombelastography. Acute Card Care 2008;10:62-63. (Pubitemid 351878183)
22. Hobson A, Curzen N. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting. Thromb Haemost 2009;101:23-30.
23. Hobson A, Qureshi Z, Banks P, Petley G, Curzen N. Gender and responses to aspirin and clopidogrel: Insights using short thrombelastography. Cardiovasc Ther 2009;27:246-252.
24. Cotton JM, Worrall AM, Hobson AR, Smallwood A, Amoah V, Dunmore S, et al. Individualised assessment of response to clopidogrel in patients presenting with acute coronary syndromes: a role for short thrombelastography? Cardiovasc Ther 2010;28:139-46.
25. Bochsen L, Winberg B, Kjelgaard-Hansen M, Steinbruchel DA, Johansson PI. Evaluation of the TEG platelet mapping assay in blood donors. Thromb J 2007;5:3.
26. Hobson A, Quereshi Z, Banks P, Curzen NP. Effects of clopidogrel on ''aspirin specific'' pathways of platelet inhibition. Platelets 2009;20:386-390.
27. Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, et al. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: A 12-month follow up. Circulation 2009;119:237-242.
28. Price MJ, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JP, et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 2008;29:992-1000. (Pubitemid 351844676)
29. Cuisset T, Hamilos M, Sarma J, Sarno G, Wyffels E, Vanderheyden M, et al. Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. Am J Cardiol 2008;101:1700-1703.
30. Blindt R, Stellbrink K, de Taeye A, Mü ller R, Kiefer P, Yagmur E, et al. The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis. Thromb Haemost 2007;98:1329-1334. (Pubitemid 350239106)
31. Gurbel PA, Bliden KP, Samara W, Yoho JA, Hayes K, Fissha MZ, Tantry US. Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study. J Am Coll Cardiol 2005;46:1827-1832. (Pubitemid 41579803)
32. Chen WH, Lee PY, Ng W, Tse HF, Lau CP. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous intervention despite clopidogrel pre-treatment. J Am Coll Cardiol 2004;43:1122-1126. (Pubitemid 38353000)
33. Barragan P, Bouvier JL, Roquebert PO, Macaluso G, Commeau P, Comet B, et al. Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of Vasodilator-Stimulated Phosphoprotein Phosphorylation. Catheter Cardiovasc Interv 2003;59:295-302. (Pubitemid 36792384)
34. Cattaneo M. Update on antithrombotic therapy. New P2Y12 inhibitors. Circulation 2010;121:171-179.
35. Bonello L, Camoin-Jau L, Armero S, Com O, Arques S, Burignat-Bonello C, et al. Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and sub-acute stent thrombosis. Am J Cardiol 2009;103:5-10.
36. Englyst N, Horsfield G, Kwan J, Byrne CD. Aspirin resistance is more common in lacunar strokes than embolic strokes and is related to stroke severity. J Cereb Blood Flow Metab 2008;28:1196-1203. (Pubitemid 351733359)
37. Armstrong PCJ, Dhanji A-RA, Tucker AT, Mitchell JA, Warner TD. Reduction of platelet Thromboxane A2 production ex vivo and in vivo by clopidogrel therapy. J Thromb Haemost 2010;8:613-615.